Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017206940) METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/206940 International Application No.: PCT/CN2017/086942
Publication Date: 07.12.2017 International Filing Date: 02.06.2017
IPC:
A61K 9/107 (2006.01) ,A61K 9/48 (2006.01) ,A61K 31/7068 (2006.01) ,A61P 35/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
107
Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7052
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706
containing six-membered rings with nitrogen as a ring hetero atom
7064
containing condensed or non-condensed pyrimidines
7068
having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
INNOPHARMAX, INC. [CN/CN]; 9F., No.22, Lane 478, Rueiguang Rd. Neihu District Taipei 11492, Taiwan, CN
Inventors:
HAO, Wei-Hua; CN
HSUEH, Shu-Piing; CN
HSU, Chang-Shan; CN
Agent:
GE CHENG & CO., LTD.; Level 19, Tower E3, The Towers, Oriental Plaza No.1, East Chang An Avenue Dongcheng District Beijing 100738, CN
Priority Data:
62/344,66002.06.2016US
Title (EN) METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY
(FR) GEMCITABINE MÉTRONOMIQUE ADMINISTRÉE PAR VOIE ORALE POUR LE TRAITEMENT DU CANCER
Abstract:
(EN) Use of gemcitabine, including in self-emulsifying orally administered dosage forms for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Gemcitabine is orally administered in a metronomic manner.
(FR) L'invention concerne l'utilisation de gemcitabine, y compris dans des formes posologiques à administration orale auto-émulsifiantes pour le traitement, par exemple l'induction de la régression ou l'inhibition de la croissance, de tumeurs chez un patient tel qu'un être humain. La gemcitabine est administrée par voie orale de manière métronomique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)